Skip to main content

Navigating Patient Needs Remotely: Addressing Challenges in Patient Access

Addressing Challenges and Mitigating Risks During the COVID-19 Pandemic and Beyond

May 20, 2020
Arnold & Porter Webinar Series: Pharma 3.0

During the second webinar in our series on "Addressing Challenges and Mitigating Risks During the COVID-19 Pandemic and Beyond," our panel covered the following topics:

  • the effects of insurance loss / economic disruption on patient access,
  • PAP eligibility rule changes and assessments,
  • social distancing and nurse support / field reimbursement support,
  • data privacy and security considerations, and
  • patient access to infused medications.

» Download the full slide deck

About the Webinar Series

Life sciences companies are doing their best to conduct business through remote customer interactions, and many expect that the expanded use of such technologies will persist well beyond the current crisis. While the life sciences industry can address many healthcare practitioner (HCP) and patient needs in this manner, the general rules, guidances and codes governing such interactions were not necessarily written with remote interactions in mind. Thus, enforcement risks may emerge in the absence of careful planning and strong safeguards.

Our webinar series delves into these issues to (1) identify the potential legal, regulatory and compliance risks, and (2) provide practical considerations for planning and successful implementation.

Meet the Speakers

Ariane M. Horn
Arnold & Porter
John Gould
Arnold & Porter
Nancy L. Perkins
Arnold & Porter
Nora Schneider
Senior Associate
Arnold & Porter